Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
402.27
+8.20 (2.08%)
At close: May 19, 2026, 4:00 PM EDT
399.26
-3.01 (-0.75%)
After-hours: May 19, 2026, 7:48 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $388.95. The average 1-year stock price forecast is 3.31% lower than the current stock price, while the lowest is $331 (-17.72%) and the highest is $474 (+17.83%).
Price Target: $388.95 (-3.31%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 6 | 6 |
| Buy | 6 | 7 | 7 | 7 | 6 | 6 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 18 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $405 → $435 | Hold → Strong Buy | Upgrades | $405 → $435 | +8.14% | Apr 29, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $397 → $411 | Buy | Maintains | $397 → $411 | +2.17% | Apr 28, 2026 |
| Barclays | Barclays | Buy Maintains $393 → $408 | Buy | Maintains | $393 → $408 | +1.42% | Apr 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $396 → $399 | Strong Buy | Maintains | $396 → $399 | -0.81% | Apr 24, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $345 → $360 | Hold | Maintains | $345 → $360 | -10.51% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
196.27B
from 199.13B
Decreased by -1.43%
Revenue Next Year
201.12B
from 196.27B
Increased by 2.47%
EPS This Year
27.17
from 25.21
Increased by 7.79%
EPS Next Year
29.42
from 27.17
Increased by 8.28%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 207.8B | 217.4B | |||
| Avg | 196.3B | 201.1B | |||
| Low | 186.2B | 190.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.4% | 10.7% | |||
| Avg | -1.4% | 2.5% | |||
| Low | -6.5% | -3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 29.66 | 32.55 | ||||||
| Avg | 27.17 | 29.42 | ||||||
| Low | 26.19 | 27.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 17.7% | 19.8% | ||||||
| Avg | 7.8% | 8.3% | ||||||
| Low | 3.9% | 2.7% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.